NIH tamped down any fear of mass revocation of oxygen on its FAQ page: Medicare current coverage policy for home oxygen therapy is flexible enough to cover patients with moderate COPD who may have hypoxia-related symptoms or findings that might be expected to improve with oxygen therapy, if providers and patients make that decision.